Discover how Basilea Pharmaceutica Ltd (XSWX:BSLN) tripled its operating profit and expanded its portfolio amidst market challenges.

Ondine’s innovative light-activated antimicrobial treatment has the potential to become the first FDA-approved nasal decolonization treatment for the prevention of surgical site infections. The ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of bacterial growth on the company’s implant ...

New study explores the use of Random Antimicrobial Peptide Mixtures (RPMs) as a safe and effective alternative to antibiotics in cultured meat ...

This study uncovers key morphological and ultrastructural similarities between cable bacteria genera. The periplasmic ...

ALDERLEY PARK, Cheshire - Infex Therapeutics Holdings plc, a UK-based anti-infectives specialist, in partnership with Justus-Liebig-University Giessen (JLU) in Germany, has been awarded a £1 million ...

Infex Therapeutics, the Alderley Park-based anti-infectives specialist, has been awarded a £1m grant, alongside Germany’s ...

SUMBAWANGA: SUMBAWANGA District Commissioner Nyakia Chirukie has confirmed that a cholera outbreak in three wards of the ...

AbbVie announced that the US FDA has approved aztreonam and avibactam (Emblaveo), in combination with metronidazole, for ...

ARE you having a lovely long weekend with your significant other this Valentine’s Day and the two of you have booked a romantic getaway? Unless you own a cosy cottage somewhere, you most ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.